Successful treatment of preadolescents with small cell carcinoma of the ovary hypercalcemic type
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Jan 2013 · 1 min read
In brief
In brief
Two preadolescent patients with advanced-stage small cell carcinoma of the ovary hypercalcemic type achieved long-term remission through aggressive multimodal treatment combining cisplatin-based chemotherapy, surgical resection, and in one case high-dose chemotherapy with stem cell rescue, radiation, and bevacizumab maintenance. Both patients remain disease-free at 7 years and 30 months post-diagnosis.
Written by the GCMD Library team from the article.
Statements in this article
Small cell carcinoma of the ovary hypercalcemic type is a rare tumor with a peak incidence in young adulthood that historically has carried a poor prognosis.
Two advanced stage cases of SCCOHT in preadolescents were successfully treated with a combination of cisplatin-based chemotherapy and surgical resection.
One patient underwent consolidative high-dose chemotherapy with stem cell rescue and external beam radiotherapy.
Therapy was concluded with a maintenance course of bevacizumab in one patient.
The patients are disease-free 7 years and 30 months, respectively, after diagnosis.
With aggressive multimodal therapy SCCOHT is curable in children.